Tag: access to health
The revolutionary HIV prevention tool, injectable lenacapavir, will be available at a cost of US$40 a year in 120 low- and middle-income countries starting...
In advance of the September 2024 WHO pandemic negotiations (INB 11), Knowledge Ecology International (KEI), Innovarte, and Medicines Law & Policy (ML&P) will convene...
The Briefing: Critical Issues before INB 11 for a Fair Pandemic Treaty was successfully held on August 29th. This event brought together experts and...
In an important meeting, Luis Villarroel and James Love met with Javiera Menay, chief of staff for the Minister of Health of Chile. The...
Today, a meeting was held between the Director of Innovarte, Luis Villarroel, and the Chief of Staff of the Undersecretary of Economy and Small...
We invite you to read the following article on the importance of transparency in the costs of medicines and health products, which the WHO...
On 21 May 2024, Wemos, together with KEI, Health Action International (HAI), Innovarte, Medicines Law & Policy, UAEM and Afya na Haki, organized an...
We share an interesting article from Innovarte ONG, written by Adán González, about licenses of right, a type of voluntary licenses established in some...
Access to medicines in pandemics: what is it all about?Tuesday 21 May 2024, 15:00-16:30 CEST, 9:00-10:30 CHILE.
Join us for an informative webinar on the...
We share an interesting article from Innovarte ONG, which reflects on how the negotiations of the Pandemic Treaty have been diluting the principles of...
